McKesson Corporation
McKesson Announces First Quarter 2025 Results and Raises Fiscal 2025 Guidance
Summary
McKesson Corporation reported its first quarter results for fiscal 2025, showing a 6% increase in revenues to $79.3 billion. The company's adjusted earnings per diluted share increased by 8% to $7.88. McKesson's Board of Directors approved a 15% increase in the quarterly dividend to $0.71 per share and a $4.0 billion increase in the share repurchase program, totaling $9.9 billion as of July 2024. The company also raised its fiscal 2025 adjusted earnings per diluted share guidance range to $31.75 to $32.55, indicating 16% to 19% growth compared to the prior year.
Profitelligence Alerts
Get alerts for MCK
Be first to know when McKesson Corporation files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About McKesson Corporation
McKesson Corporation is a leading healthcare services and information technology company. It plays a crucial role in the distribution of pharmaceuticals and medical products. The primary function of McKesson is to ensure the efficient delivery of healthcare products to pharmacies, hospitals, and other medical facilities, ensuring that millions of patients have access to the medications they need. It also provides specialized software and automated solutions that enhance operational efficiency in healthcare sectors. McKesson significantly impacts the pharmaceutical and healthcare industries by offering solutions that streamline supply chains and improve patient care. Its services encompass wholesale drug distribution, healthcare IT systems, and pharmacy management. With operations that extend globally, McKesson is integral to maintaining the integrity and reliability of healthcare supply networks. By handling a substantial portion of the pharmaceutical distribution in North America, McKesson Corporation has a vital market presence, emphasizing its importance in shaping healthcare logistics and innovation. Its efforts contribute to advancing healthcare delivery and responding to the evolving demands of the medical industry.
Official SEC Documents
Advertisement